Hall MR, Dehbi HM, Banerjee S, Lord R, et al. A phase II randomised, placebo-controlled trial of low dose (metronomic) cyclophosphamide and nintedanib (BIBF1120) in advanced ovarian, fallopian tube or primary peritoneal cancer. Gynecol Oncol 2020 Oct 16. pii: S0090-8258(20)33958.
PMID: 33077258